7
total announcements
531739.BO · 15 min delayed
Gennex Laboratories Ltd
Gennex Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 to consider and approve the conduct of 41st AGM for the year ended March 31, 2026, and other matters.
Gennex Laboratories Ltd
Gennex Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with total income from operations at ₹3,667.49 crore and profit after tax at ₹305.53 crore.
Gennex Laboratories Ltd
Gennex Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 395.53 lakhs and a total comprehensive income of Rs. 395.53 lakhs.
Gennex Laboratories Ltd
Gennex Laboratories Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 395.53 lakhs. The company's total income was Rs. 3,667.49 lakhs, with expenses totaling Rs. 3,246.96 lakhs. The results have been reviewed by the Audit Committee and approved by the Board of Directors.
Gennex Laboratories Ltd
Gennex Laboratories Ltd has announced that its Board of Directors will meet on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The meeting is in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Gennex Laboratories Ltd
Gennex Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve the Unaudited Financial Statements for the Quarter ended June 30, 2026.
Gennex Laboratories Ltd
Gennex Laboratories Ltd has announced the closure of its trading window for insiders from July 01, 2026, until 48 hours after the public announcement of its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The date for the Board Meeting to approve these results will be intimated in due course.